Skip navigation
FACT
Focus on Alternative and Complementary Therapies
Home > FACT > FACT contents > Volume 10 2005 > Volume 10:4 December 2005 > Focus

Focus Altern Complement Ther 2005; 10: 271–4

Spa therapy for treating chronic low back pain

Max H Pittler

Keywords

  • Spa therapy
  • chronic low back pain
  • systematic review
  • randomised controlled trial

Background

One of the major public health concerns is chronic low back pain.15 In the UK, for instance, low back pain is the largest single cause of absence from work and responsible for 12.5% of all sick days.6 Among patients who suffer from chronic low back pain complementary therapies are popular treatment options.7 Two such treatment options are balneotherapy and spa therapy, which are, at least in part, reimbursed by many European health insurance systems. Balneotherapy is defined as baths using thermal mineral waters at temperatures of at least 20 °C and a mineral content of at least 1 g per litre of water from natural springs. Spa therapy additionally employs physiotherapeutic interventions at a spa resort.8,9 In some countries, such as the UK and the USA, these treatments are viewed as complementary. Elsewhere, they have traditionally been considered mainstream, e.g. Germany, Italy and Hungary. Balneo- and spa therapies are associated with considerable costs and it is therefore reasonable to question if they are supported by good evidence. The objective of this assessment was to evaluate the evidence of the effectiveness of spa therapy for treating chronic low back pain.

The databases Medline, Embase, Cochrane Central and Amed were searched from their respective inceptions until April 2005. Hand-searches included bibliographies of all retrieved articles. There were no restrictions regarding the language of publication. Studies were included if they were described as randomised trials testing spa therapy for treating patients with chronic low back pain. Trials reported in duplicate were excluded. Methodological quality was evaluated using the system developed by Jadad et al.10 The primary endpoint was defined as the mean change of pain measured on the 100 mm VAS compared with baseline, which was used to assess intergroup differences. Standard meta-analysis software (RevMan 4.2.8, Update Software Ltd, Oxford, UK) was used to calculate means and 95% CI. Summary estimates of the treatment effect were calculated using a random effects model and the chi-square test for heterogeneity was performed.

Results

After assessing their abstracts, 8 potentially relevant papers were retrieved for further evaluation.1118 No unpublished studies were identified. Five publications did not meet the inclusion criteria and were excluded.1115 Three other trials1618 could be included and provided data that were suitable for statistical pooling (Table 1).

Table 1. RCTs of spa therapy for chronic low back pain

First author [reference], yearDesign, quality scoreInterventionWater mineralisation, constituentsDurationControln randomised/n analysedMain outcome measuresIntergroup differencesConcomitant treatment
Spa therapy         
Guillemin [16] 1994Two parallel groups, 215-min high-pressure water massage at 36° C water temperature< 500 mg/l, mainly sulphate, sodiumDaily for 6 days, weekly for 3 weeksWaiting list104/102100 mm pain VASP < 0.0001 for all main outcome measuresNone
  Series of 3-min water massages with varying pressures and temperatures (31 to 36° C)    Schober score  
       Waddel index  
Constant [17] 1995Two parallel groups, 310-min bath at 36° C with underwater flow8073 mg/l, mainly bicarbonate, sodiumDaily for 6 days, weekly for 3 weeksWaiting list126/121100 mm pain VASP < 0.0001 and P = 0.38, respectivelyRoutine drug treatment
  20-min local mud application at 45° C    Schober score  
  2.5-min high-pressure shower at 36° C with a massage device and regulated pulse flow       
Constant [18] 1998Two parallel groups, 210-min bath at 36° C with underwater flow510 mg/lOne and two daily for 6 days, weekly for 3 weeksWaiting list224/219100 mm pain VASP < 0.0001, P = 0.22 and P < 0.05, respectivelyRoutine drug treatment
  15-min local mud application at 45° C Three every other day for 3 weeks  Schober score  
  20-min massage under flowing water at 36° C    Quality of life  

Quality score: maximum 5

Spa therapy was tested in three RCTs. In all studies pain was assessed using 100 mm VAS. The meta-analysis suggests significant differences in favour of spa therapy compared with waiting list control groups (weighted mean difference: −26.6, 95% CI −20.4 to −32.8, n = 442). Results for the Schober index suggest no significant intergroup differences (weighted mean difference: 3.6 mm, 95% CI −2.7 to 9.8, n = 442). In all three trials there was no mention of adverse events.

Comment

The meta-analysis suggests a significant differential effect in favour of spa therapy for reducing chronic low back pain. However, the volume of the evidence is small and included only three RCTs assessing 454 patients.

This paucity of evidence from RCTs is in stark contrast to the popularity among patient populations and to the expenditure by health insurances on spa therapeutic interventions. The findings of our meta-analysis support data from previous systematic reviews, which identified the need for further studies some 7 years ago.19 Methodological difficulties in assessing these complex interventions, particularly the design of an adequate sham- or placebo-control group and the expenses involved, may be some of the reasons for the small number of studies carried out so far. Nonetheless, good quality trials are possible, as indicated by the Jadad scores (Table 1) and it is hoped that our findings will encourage further systematic research. Future studies should be randomised and careful attention should be paid to the concealment of treatment allocation, as was done in all studies on spa therapy. Adequate sample sizes should be assessed, ideally administering similar regimens under similar conditions. The design of the control group requires careful attention to minimise bias, particularly when subjective outcome measures are assessed, such as pain. In contrast to other opinions,20 we believe that balneo- and spa therapies are examples of complex interventions where delineating specific from non-specific effects is possible and required.

Trials are also needed to investigate the more fundamental question of whether spa treatments administered at a spa resort are more beneficial than the same treatments administered in a non-residential setting at home. These differences are at the heart of spa therapy and are associated with considerable costs. At present, there is no convincing evidence that spa therapy with treatments administered at a spa resort is more effective than the same treatment regimen administered at home.19 Thus, a situation exists whereby some encouraging evidence suggests that spa therapy is effective for low back pain, while it is unclear whether these treatments have to be administered at a spa resort, as an integral part of spa therapy or can be administered at home with the same therapeutic effect.

In some countries, such as Germany, the spa sector has suffered through political decisions to cut back on reimbursing such treatments (‘Kur’) through national health insurance systems. This move was motivated by financial considerations but the paucity of compelling data on specific effectiveness and cost-effectiveness also played a crucial role. Considering the potential role of spa therapy as evidenced by this meta-analysis it is disappointing that more clinical trials have not been initiated. Table 1 shows that since 1998 no RCTs of spa therapy for low back pain have been carried out. As always, the burden of demonstrating the value of a medical intervention lies on the shoulders of those who claim that it works.

In conclusion, these findings show that there is some encouraging evidence to suggest that spa therapy is effective for treating chronic low back pain. However, these data are by no means compelling and rigorous large-scale trials need to be carried out to verify these findings.

References

  1. Walker BF, Muller R, Grant WD. Low back pain in Australian adults: prevalence and associated disability. J Manipulative Physiol Ther 2004; 27: 238–44. [Abstract]
  2. da Silva MC, Fassa AG, Valle NC. Chronic low back pain in a Southern Brazilian adult population: prevalence and associated factors. Cad Saude Publica 2004; 20: 377–85.
  3. Stranjalis G, Tsamandouraki K, Sakas DE, Alamanos Y. Low back pain in a representative sample of Greek population: analysis according to personal and socioeconomic characteristics. Spine 2004; 29: 1355–60. [Abstract]
  4. Palmer KT, Walsh K, Bendall H et al. Back pain in Britain: comparison of two prevalence surveys at an interval of 10 years. BMJ 2000; 320: 1577–8. [Abstract]
  5. Feuerstein M, Marcus SC, Huang GD. National trends in nonoperative care for nonspecific back pain. Spine J 2004; 4: 56–63. [Abstract]
  6. Andersson GB. Epidemiological features of chronic low-back pain. Lancet 1999; 354: 581–5. [Abstract]
  7. Barnes PM, Powell-Griner E, McFann K, Nahin RL. Complementary and alternative medicine use among adults: United States, 2002. Adv Data 2004; 343: 1–19.
  8. Bender T, Karagülle Z, Balint GP et al. Hydrotherapy, balneotherapy, and spa treatment in pain management. Rheumatol Int 2005; 25: 220–4. [Abstract]
  9. Pätzold C, Engst R. Pschyrembel Wörterbuch Naturheilkunde. Berlin, New York: de Gruyter, 2000.
  10. Jadad AR, Moore RA, Carroll D et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1–12. [Abstract]
  11. Krajnc I, Siftar M, Turk Z et al. The effect of balneotherapy on the low back pain disease at the Moravci spa and the Department of Physiotherapy and Rheumatology – Maribor Teaching Hospital. Scand J Rheumatol 1992; (Suppl. 94): 55.
  12. Peter A, Cornut JP, Zenklusen JL, Pfister JA. The patient with chronic low back pain in a thermal spa. Schweiz Rundsch Med Prax 1993; 82: 1004–7.
  13. Rozier M, Francon J, Gras-Joly JPJ. Clinical study of voltaren in 58 patients in a thermal bath environment. Rheumatologie 1978; 30: 133–5.
  14. Queneau P, Francon A, Graber-Duvernay B. Methodological reflections on 20 randomized clinical hydrotherapy trials in rheumatology. Therapie 2001; 56: 675–84.
  15. Constant F, Guillemin F, Herbeth B et al. Measurement methods of drug consumption as a secondary judgment criterion for clinical trials in chronic rheumatic diseases. Am J Epidemiol 1997; 145: 826–33.
  16. Guillemin F, Constant F, Collin JF, Boulange M. Short-and long-term effect of spa therapy in chronic low back pain. Br J Rheumatol 1994; 33: 148–51. [Abstract]
  17. Constant F, Collin JF, Guillemin F, Boulange M. Effectiveness of spa therapy in chronic low back pain: a randomized clinical trial. J Rheumatol 1995; 22: 1315–20.
  18. Constant F, Guillemin F, Collin JF, Boulange M. Use of spa therapy to improve the quality of life of chronic low back pain patients. Med Care 1998; 36: 1309–14. [Abstract]
  19. Ernst E, Pittler MH. How efficacious is spa treatment? A systematic review of randomized trials. Dtsch Med Wochenschr 1998; 123: 273–7.
  20. Paterson C, Dieppe P. Characteristic and incidental (placebo) effects in complex interventions such as acupuncture. BMJ 2005; 330: 1202–5. [Abstract]
Max H Pittler, MD, PhD is an Associate Editor of FACT and a Research Fellow in Complementary Medicine at the Peninsula Medical School, Universities of Exeter and Plymouth, 25 Victoria Park Road, Exeter EX2 4NT, UK.
Top | Next: Sample size calculations, pilot studies and confidence intervals: where is the evidence?»
© Pharmaceutical Press 2008
Accessibility | Terms and Conditions